ArticleJournal of gastroenterology and hepatology2025

Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment.

Eiichi Ogawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.